Hero Background
Hero Foreground

DIFFERENT

MAKES A DIFFERENCE

Experience UMBC this Fall

Attend an upcoming event and see all that UMBC has to offer first-year and transfer students.

Register for an Event

14,000

STUDENTS

#19

MOST INNOVATIVE SCHOOLS

Top 100

PUBLIC INSTITUTION IN FEDERAL RESEARCH SUPPORT

270+

STUDENT GROUPS

View More UMBC Facts & Figures →

umbc's campus featuring brick buildings and striped walkways

U.S. News highlights UMBC’s national leadership in teaching, innovation, and diversity.

US News Best Colleges National Public Universities 2026
US News Best Colleges Best Value Schools 2026
US News Most Innovative 2026
US News Undergraduate Teaching 2026

Life at UMBC

Our UMBC community is committed to helping you achieve excellence as a student and beyond. Whether breaking boundaries in the classroom and the lab, or stretching your limits on stage or the playing field, Retrievers are in it #UMBCTogether.

UMBC is a R1 research university recognized for innovation, undergraduate teaching, and student success.

From hands-on research and faculty mentorship to campus traditions, leadership opportunities, and strong career outcomes, UMBC helps students discover their potential and prepare for what’s next.

Here, different makes a difference.

UMBC research team discovers promising molecular target for ovarian cancer treatment
Feature

UMBC research team discovers promising molecular target for ovarian cancer treatment

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30 percent. Further complicating treatment, standard therapies cause substantial harm to healthy cells alongside cancerous ones. But what if ovarian cancer treatment could more specifically target cancerous cells, causing less harm to the rest of the body? New research from Achuth Padmanabhan’s lab offers hope in the form of a potential molecular target for new cancer drugs: an enzyme called USP15, which ovarian cancer cells appear to rely on more heavily than normal cells. Biological sciences Ph.D. student Ayokunnumi “Ayo” Ogunsanya led the work, which showed that lowering USP15 levels causes a constellation of effects that make it a prime target for new treatments.

Read the story